Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Pharma-Bio Serv Inc. (PBSV) had Return on Equity of 2.23% for the most recently reported fiscal quarter, ending 2026-04-30.
| Income Statement Financials | |
$2.70M |
|
$0.23M |
|
$1.80M |
|
$0.90M |
|
$2.56M |
|
$0.14M |
|
$0.09M |
|
$0.24M |
|
$0.24M |
|
$0.23M |
|
$0.23M |
|
$0.23M |
|
$0.23M |
|
$0.14M |
|
$0.16M |
|
22.90M |
|
22.91M |
|
$0.01 |
|
$0.01 |
|
| Balance Sheet Financials | |
$11.29M |
|
$0.09M |
|
$0.21M |
|
$11.50M |
|
$1.05M |
|
-- |
|
-- |
|
$1.05M |
|
$10.45M |
|
$10.45M |
|
$10.45M |
|
22.90M |
|
| Cash Flow Statement Financials | |
$-0.76M |
|
$0.88M |
|
$-1.72M |
|
$3.38M |
|
$1.79M |
|
$-1.59M |
|
$0.02M |
|
$-1.72M |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.80 |
|
-- |
|
-- |
|
-- |
|
-- |
|
33.37% |
|
5.35% |
|
5.35% |
|
-- |
|
8.86% |
|
8.62% |
|
$-0.75M |
|
-- |
|
-- |
|
-- |
|
0.24 |
|
-- |
|
0.99 |
|
90.68 |
|
|
Return on Equity |
2.23% |
2.23% |
|
2.03% |
|
2.23% |
|
$0.46 |
|
$-0.03 |
|
$-0.03 |
|